Search form


Press Releases

Axcan Pharma to be Included in the New NASDAQ Global Select Market(SM)

Jun 29, 2006 - 05:00 ET

MONT SAINT-HILAIRE, QUEBEC--(CCNMatthews - June 29, 2006) - Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that it will be included in the new NASDAQ Global Select Market(SM).

Axcan is currently listed on the NASDAQ National Market®, which is being renamed the NASDAQ Global Market(SM). Effective from July 3, 2006, Axcan will be listed on the NASDAQ Global Select Market(SM), a tier of the NASDAQ Global Market(SM) with superior initial listing standards. According to NASDAQ®, the standards for the new NASDAQ Global Select Market(SM) have higher financial and liquidity requirements than any other market. NASDAQ®'s high corporate governance standards are also incorporated in the NASDAQ Global Select Market(SM) selection criteria.

"We are very pleased to be informed that Axcan qualifies to be listed on the market with the highest listing standards in the world," commented Frank Verwiel, M.D., President and Chief Executive Officer of Axcan. "This achievement portrays a strong message of our dedication to high standards and excellent corporate governance within the Company."

Axcan's common shares will be listed on the NASDAQ Global Select Market(SM) under the same symbol ("AXCA").

About Axcan Pharma

Axcan is a leading specialty pharmaceutical company involved in the field of gastroenterology. The Company markets a broad line of prescription products sold for the treatment of symptoms in a number of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to cystic fibrosis. Axcan's products are marketed by its own sales force in North America and Europe. Its common shares are listed on the Toronto Stock Exchange under the symbol "AXP" and on the NASDAQ National Market® under the symbol "AXCA".

Axcan Pharma Inc.
Isabelle Adjahi
Director, Investor Relations
(450) 467-2600 ext. 2000